Hepatocellular carcinoma and aflatoxin in Sudan: The way forward

Abstract

Hepatocellular carcinoma (HCC) is the sixth most common type of cancer and the third leading cause of death worldwide. It is especially  prevalent in developing countries, with around 80% of cases occurring in Asia and Africa. Aflatoxin B1 is a well-documented risk factor for  HCC, among other factors. In Sudan, there is limited reliable and comprehensive data on cancer epidemiology, including HCC. This paper  focuses on the current status of HCC in Sudan, specifically in relation to aflatoxin. Additionally, recommendations are provided to  enhance the control measures for HCC in the country.